ArticleCancer management and research2022

Feasibility and Safety of Anlotinib Monotherapy for Patients with Previously Treated Advanced Esophageal Squamous Cell Carcinoma: A Real-World Exploratory Study.

Song Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.